
    Original Text: Concurrently using other anticancer therapy. Participants must continue palbociclib and AI or fulvestrant for Phase 1b and palbociclib or ribociclib and AI or fulvestrant for Phase 2.
    Disease/Condition: none
    Procedure: none
    Drug: none
    Biomarker: none
    Computable Rule: "Concurrently using other anticancer therapy" is False

Criterion:
    Patients with metastatic breast cancer who have progressed on endocrine therapy and chemotherapy, and have measurable disease at baseline.

Output:
    Original Text: Patients with metastatic breast cancer who have progressed on endocrine therapy and chemotherapy, and have measurable disease at baseline.
    Disease/Condition: Metastatic Breast Cancer
    Procedure: Endocrine Therapy
    Drug: Chemotherapy
    Biomarker: Measurable Disease
    Computable Rule: "Metastatic Breast Cancer" AND "